X

Home
Research
Members
- Current Lab Members
- Alumni Lab Members
Publications
Protocols
Videos
Resources
Open-Access
News
Events
Contact
Menu Menu

Blood-Clotting Protein Could be a Target for Therapy against MS

May 14, 2007

Read National Institute of Neurological Disorders and Stroke article →

Share this entry

Share on Facebook
Share on X
Share on X
Share on LinkedIn
Share by Mail

https://akassogloulab.org/wp-content/uploads/2007/06/nih-squarelogo.png 180 180 awp-admin /wp-content/uploads/2017/01/katerina-akassoglou-lab-all-caps-gladstone-ucsf-501x133-new.png awp-admin2007-05-14 18:49:212023-04-10 15:54:41Blood-Clotting Protein Could be a Target for Therapy against MS

Latest News

Fibrin fuels thromboinflammation and brain damage in COVID-19November 27, 2024 - 6:30 pm
Preventing Brain Damage in Preterm BabiesAugust 29, 2024 - 9:07 pm
Discovery of How Blood Clots Harm Brain and Body in COVID-19 Points to New TherapyAugust 29, 2024 - 9:07 pm
Katerina Akassoglou Receives 2024 Pharmacia-ASPET AwardJune 29, 2024 - 9:06 pm
A New Therapeutic Target for Traumatic Brain InjuryMay 26, 2024 - 9:56 pm

More News →

Katerina Akassoglou, Ph.D.

Gladstone Institute of Neurological Disease
1650 Owens Street
San Francisco, CA 94158

415-734-2512 (Phone)
415-355-0824 (Fax)
kakassoglou@gladstone.ucsf.edu

Followon X Subscribeto RSS Feed

Affiliates

GIND - Gladstone Institutes Neurological Disease

UCSF Neurology

© Copyright Akassoglou Lab. All rights reserved.

X

Home
Research
Members
Publications
Protocols
Videos
Resources
Open-Access
News
Events
Contact

Blood clotting protein may inhibit spinal cord regeneration

bsp_profile_image_white_400x400

Blood-Clotting Protein Could be a Target for Therapy against MS